DSIJ Mindshare

Dr Reddys gets safe recommendation for third phase of Sputnik V clinical trial

Shreya Chaware 0 855 Article rating: 3.7

Dr Reddy's Laboratories on Monday post-market hours informed that the independent Data & Safety Monitoring Board (DSMB) has reviewed the safety data from phase 2 clinical trial of Sputnik V vaccine and has given the approval to go ahead with phase 3 clinical trial after necessary prerequisites, without any modifications. 

KEC International climbs over 1 per cent on attaining new orders across various businesses

Shreya Chaware 0 1428 Article rating: 2.3

KEC International announced during the weekend that it has received new orders across its various businesses. The orders, which amount to up to Rs 1,024 crore in total, have been received in various segments such as transmission & distribution, railways, civil, solar, and cables.  

RSS
First150151152153155157158159
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR